Lactobacillus rhamnosus could inhibit Porphyromonas gingivalis derived CXCL8 attenuation
Ayşegül Mendi, Sevil Köse, Duygu Uçkan, Gülçin Akca, Derviş Yilmaz, Levent Aral, Sibel Elif Gültekin, Tamer Eroğlu, Emine Kiliç, Sina Uçkan, Ayşegül Mendi, Sevil Köse, Duygu Uçkan, Gülçin Akca, Derviş Yilmaz, Levent Aral, Sibel Elif Gültekin, Tamer Eroğlu, Emine Kiliç, Sina Uçkan
Abstract
An increasing body of evidence suggests that the use of probiotic bacteria is a promising intervention approach for the treatment of inflammatory diseases with a polymicrobial etiology. P. gingivalis has been noted to have a different way of interacting with the innate immune response of the host compared to other pathogenic bacteria, which is a recognized feature that inhibits CXCL8 expression.
Objective: The aim of the study was to determine if P. gingivalis infection modulates the inflammatory response of gingival stromal stem cells (G-MSSCs), including the release of CXCL8, and the expression of TLRs and if immunomodulatory L. rhamnosus ATCC9595 could prevent CXCL8 inhibition in experimental inflammation.
Material and methods: G-MSSCs were pretreated with L. rhamnosus ATCC9595 and then stimulated with P. gingivalis ATCC33277. CXCL8 and IL-10 levels were investigated with ELISA and the TLR-4 and 2 were determined through flow cytometer analysis.
Results: CXCL8 was suppressed by P. gingivalis and L. rhamnosus ATCC9595, whereas incubation with both strains did not abolish CXCL8. L. rhamnosus ATCC9595 scaled down the expression of TLR4 and induced TLR2 expression when exposed to P. gingivalis stimulation (p<0.01).
Conclusions: These findings provide evidence that L. rhamnosus ATCC9595 can modulate the inflammatory signals and could introduce P. gingivalis to immune systems by inducing CXCL8 secretion.
Conflict of interest statement
CONFLICT OF INTERESTS
Authors declare no conflict of interests.
Figures
References
- Armitage GC. Classifying periodontal diseases - a long-standing dilemma. Periodontol 2000. 2002;30(1):9–23.
- Bernet MF, Brassart D, Neeser JR, Servin AL. Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions. App Environ Microbiol. 1993;59(12):4121–4128.
- Bizzini B, Pizzo G, Scapagnini G, Nuzzo D, Vasto S. Probiotics and oral health. Curr Pharm Des. 2012;18(34):5522–5531.
- Bleau C, Monges A, Rashidan K, Laverdure JP, Lacroix M, van Calsteren MR, et al. Intermediate chains of exopolysaccharides from Lactobacillus rhamnosus RW-9595M increase IL-10 production by macrophages. J Appl Microbiol. 2010;108(2):666–675.
- Burns E, Bachrach G, Shapira L, Nussbaum G. Cutting edge: TLR2 is required for the innate response to Porhyromonas gingivalis: activation leads to bacterial persistence and TLR2 deficiency attenuates induced alveolar bone resorption. J Immunol. 2006;177(12):8296–8300.
- Castillo NA, Perdigón G, de Moreno de Leblanc A. Oral administration of a probiotic Lactobacillus modulates cytokine production and TLR expression improving the immune response against Salmonella enterica serovar Typhimurium infection in mice. BMC Microbiol. 2011;11:
- Coats SR, Jones JW, Do CT, Braham PH, Bainbridge BW, To TT, et al. Human Toll-like receptor 4 responses to P. gingivalis are regulated by lipid A 1- and 4’-phospatase activities. Cell Microbiol. 2009;11(11):1587–1599.
- Collado MC, Grześkowiak L, Salminen S. Probiotic strains and their combination inhibit in vitro adhesion of pathogens to pig intestinal mucosa. Curr Microbiol. 2007;55(3):260–265.
- Del Re B, Sgobarti B, Miglioli M, Palenzona D. Adhesion, autoaggregation and hydrophobicity of 13 strains of Bifidobacterium longum. Lett App Microbiol. 2000;31(6):438–442.
- Dias IH, Marshall L, Lambert PA, Chapple IL, Matthews JB, Griffiths HR. Gingipains from Porphyromonas gingivalis increase the chemotactic and respirator burst-priming properties of the 77-amino-acid interlekin-8 variant. Infect Immun. 2008;76(1):317–323.
- Elo S, Saxellin M, Salminen S. Attachement of Lactobacillus casei strain GG to human colon carcinoma cell line Caco-2: comparison with other dairy strains. Lett Appl Microbiol. 1991;13(3):154–156.
- Folwaczyn M, Glas J, Török HP, Limbersky O, Folwaczny C. Toll-like receptor (TLR) 2 and 4 mutations in periodontal disease. Clin Exper Immunol. 2004;135(2):330–335.
- Hajishengallis G, Ratti P, Harokopakis E. Peptide mapping of bacterial fimbrial epitopes interacting with pattern recognition receptors. J Biol Chem. 2005;280(47):38902–38913.
- Han Y, Shi W, Huang GT, Haake S, Park NH, Kuramitsu H, et al. Interactions between periodontal bacteria and human oral epithelial cells: Fusobacterium nucleatum adheres to and invades epithelial cells. Infect Immun. 2000;68(6):3140–3146.
- Handley PS, Harty DW, Wyatt JE, Brown CR, Doran JP, Gibbs AC. A comparison of the adhesion, coaggregation and cell surface hyrophobicityproperties of fibrilar and fimbriate strains of Streptococcus salivarius. J Gen Microbiol. 1987;133(11):3207–3217.
- Hosokawa Y, Hosokawa I, Shindo S, Ozaki K, Matsuo T. TLR 3 agonist enhances CC chemokine ligand 20 production in IL-1-β stimulated human gingival fibroblasts. Cell Immunol. 2013;283(1-2):8–11.
- Huang GT, Kim D, Lee JK, Karamitsu HK, Haake SK. Interleukin-8 and intercellular adhesion molecule 1 regulation in oral epithelial cells by selected periodontal bacteria: multiple effects of Porphyromonas gingivalis via antagonistic mechanisms. Infect Immun. 2001;69(3):1364–1372.
- Huang GT, Haake SK, Kim JW, Park NH. Differential expression of interleukin-8 and intercellular adhesion molecule-1 by human gingival epithelial cells in response to Actinobacillus actinomycetemcomitans or Porphyromonas gingivalis infection. Oral Mirobiol. Immunol. 1998;13(5):301–309.
- Kadowaki T, Takii R, Yamatake K, Kawakubo T, Tsukuba T, Yamamoto K. A role for gingipains in cellular responses and bacterial survival in Porphyromonas gingivalis infected cells. Front. Biosci. 2007;12:4800–4809.
- Kõll-Klais P, Mändar R, Leibur E, Marcotte H, Hammarström L, Mikelsaar M. Oral lactobacilli in chronic periodontitis and periodontal health: species composition and antimicrobial activity. Oral Microbiol Immunol. 2005;20(6):354–361.
- Mahanonda R, Sa-Ard-Iam N, Montreekachon P, Pimkhaokham A, Yongvanichit K, Fukuda MM, et al. IL-8 and IDO expression by human gingival fibroblasts via TLRs. J Immunol. 2007;178(2):1151–1157.
- Mendi A, Aslım B. Antioxidant lactobacilli could protect gingival fibroblasts against hydrogen peroxide: a preliminary in vitro study. Probiotics Antimicrob Proteins. 2014;6(3-4):157–164.
- Messora MR, Oliveira LF, Foureaux RC, Taba M, Jr, Zangerônimo MG, Furlaneto FA, et al. Probiotic therapy reduces periodontal tissue destruction and improves the intestinal morphology in rats with ligature-induced periodontitis. J Periodontol. 2013;84(12):1818–1826.
- Ogawa T, Asai Y, Makimura Y, Tamai R. Chemical structure and immunobiological activity of Porphyromonas gingivalis lipid A. Front Biosci. 2007;12:3795–3812.
- Palm E, Khalaf H, Bengtsson T. Porhyromonas gingivalis downregulates the immune response of fibroblasts. BMC Microbiol. 2013;13:155–163.
- Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):1168–1170.
- Piwat S, Sophatha B, Teanpaisan R. An assessment of adhesion, aggregation and surface charges of Lactobacillus strains derived from the human oral cavity. Lett Appl Microbiol. 2015;61(1):98–105.
- Tonetti MS, Imboden MA, Gerber L, Lang NP, Laisue J, Mueller C. Localized expression of mRNA for phagocyte-specific chemotactic cytokines in human periodontal infections. Infect Immun. 1994;62(9):4005–4014.
- Tuomola EM, Salminen S. Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell culture. Int J Food Microbiol. 1998;41(1):45–51.
- Zhang Q, Shi S, Liu Y, Uyanne J, Shi Y, Shi S, et al. Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis. J Immunol. 2009;183(12):7787–7798.
Source: PubMed